CLINICAL_TRIALS
trial_result
· 2017-08-08
Clinical Trial Update: Drotaverine in Dysmenorrhoea Treatment [Phase 4]
Summary
The Phase 4 trial evaluating drotaverine for dysmenorrhea has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Dysmenorrhea | Phase 4 | Status: TERMINATED